Inventor
HURTH KONSTANZE
DE27 patents
⚠️ This page may combine multiple inventors who share the name “HURTH KONSTANZE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
16 patentsUS7713976B2May 11, 2010
[(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders
NOVARTIS AG19 citations91
US7713977B2May 11, 2010
(1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
NOVARTIS AG20 citations91
US7579362B2Aug 25, 2009
Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
NOVARTIS AG17 citations91
US9475811B2Oct 25, 2016
1-aza-bicyclo[3.3.1]nonanes
NOVARTIS AG11 citations82
US8048885B2Nov 1, 2011
Organic compounds
NOVARTIS AG5 citations72
US10301296B2May 28, 2019
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG1 citations71
US10035794B2Jul 31, 2018
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG3 citations71
US6861430B2Mar 1, 2005
β-carboline derivatives and its pharmaceutical use against depression and anxiety
NOVARTIS AG7 citations71
US9567343B2Feb 14, 2017
Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists
NOVARTIS AG1 citations60
US10683287B2Jun 16, 2020
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG0 citations51
US9657010B2May 23, 2017
Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators
NOVARTIS AG0 citations51
US9206181B2Dec 8, 2015
1-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders
NOVARTIS AG0 citations51
US9849117B2Dec 26, 2017
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
NOVARTIS AG0 citations50
US9539260B2Jan 10, 2017
Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
NOVARTIS AG0 citations49
US7754719B2Jul 13, 2010
Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
NOVARTIS AG0 citations49
US9840498B2Dec 12, 2017
Substituted quinazolin-4-one derivatives
NOVARTIS AG1 citations45
FEUERBACH DOMINIK
5 patentsUS8933090B2Jan 13, 2015
1-aza-bicyclo[3.3.1]nonanes
FEUERBACH DOMINIK11 citations82
US8609662B2Dec 17, 2013
3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases
FEUERBACH DOMINIK13 citations82
US9012451B2Apr 21, 2015
Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists
FEUERBACH DOMINIK1 citations61
US8236803B2Aug 7, 2012
Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
FEUERBACH DOMINIK1 citations61
US8637517B2Jan 28, 2014
Organic compounds
FEUERBACH DOMINIK3 citations60
BADIGER SANGAMESH
3 patentsUS8637508B2Jan 28, 2014
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH75 citations95
US9550758B2Jan 24, 2017
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH4 citations82
US8865712B2Oct 21, 2014
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH7 citations82